Implementation
Research Spotlight – Development of Tools to Re-Orient Social Mobilization Strategies to Close the Coverage-Compliance Gap
It sounds simple – we ask entire communities to take medications periodically, provided free of charge, to protect themselves and their community from neglected tropical diseases (NTDs).
iChord – Improving Community Health Outcomes through Research and Dialogue: A New Approach to Community Engagement in Global Health
There are many factors to keep in mind while planning for mass drug administration (MDA) of preventative chemotherapy for neglected tropical diseases (PC-NTDs). Acquiring the drugs is only the first step – or the “first mile” in supply chain lingo.
Monitoring and Supervising the Annual Mass Drug Administration for Neglected Tropical Diseases in Ethiopia using a Rapid Coverage Survey Tool: A Case Study
Annual Mass Drug Administration (MDA) is one of the strategies used to combat Neglected Tropical Diseases (NTDs) such as trachoma, onchocerciasis, lymphatic filariasis, schistosomiasis, soil-transmitted helminthiasis (STH).
Small Grants, Big Impact: Joy Chikwendu, Makurdi, Nigeria
In May 2017, ARNTD, USAID, and COR-NTD announced the first-ever grantees of the African Researchers' Small Grants program.
Small Grants, Big Impact: Dr. Pythagore Fogue, Dschang, Cameroon
In May 2017, ARNTD, USAID, and COR-NTD announced the first-ever grantees of the African Researchers' Small Grants program.
Small Grants, Big Impact: Dr. Regina Ejemot-Nwadiaro, Cross River State, Nigeria
In May 2017, ARNTD, USAID, and COR-NTD announced the first-ever grantees of the African Researchers' Small Grants
Small Grants, Big Impact: Dr. Humphrey Mazigo, Mwanza, Tanzania
In May 2017, ARNTD, USAID, and COR-NTD announced the first-ever grantees of the African Researchers' Small Grants program.
The Value of Experience: A Novel Approach to Researching Health Behaviors
This blog describes a tool, Guidelines for Use of Narrative Survey Instruments to Improve MDA for Lymphatic Filariasis Elimination.
Q&A with Patrick Lammie, Chief Scientist for the NTD Support Center
There’s no harm in trying new strategies. When they work, great. When they don’t work, try something else.